GENINCODE PLC — Investor Relations & Filings
GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-08 | English | |
| Grant of Share Options & PDMR Dealings | 2026-05-07 | English | |
| Holding(s) in Company | 2026-02-26 | English | |
| Holding(s) in Company | 2026-02-24 | English | |
| Holding(s) in Company | 2026-02-12 | English | |
| Holding(s) in Company | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 44302284 | Holding(s) in Company | 2026-05-08 | English | ||
| 42453279 | Grant of Share Options & PDMR Dealings | 2026-05-07 | English | ||
| 32843679 | Holding(s) in Company | 2026-02-26 | English | ||
| 34563216 | Holding(s) in Company | 2026-02-24 | English | ||
| 19467055 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466908 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466858 | Holding(s) in Company | 2026-02-12 | English | ||
| 18247395 | Result of GM, Director Shareholdings and TVR | 2026-02-09 | English | ||
| 14783432 | Additional Subscription | 2026-02-06 | English | ||
| 13343227 | Result of Retail Offer | 2026-01-26 | English | ||
| 13199807 | Result of Placing and Subscription | 2026-01-22 | English | ||
| 13159849 | Retail Offer | 2026-01-21 | English | ||
| 13159846 | Placing and Subscription | 2026-01-21 | English | ||
|
2025
2 filings
| |||||
| 10225432 | Collaboration with Sohin Genetics | 2025-12-17 | English | ||
| 9627671 | Holding(s) in Company | 2025-12-08 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GENINCODE PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Kancera
Pharmaceutical company seeking a reverse takeover to levera…
|
KAN | SE | Professional, scientific and te… |
|
KAZIA THERAPEUTICS LTD
Oncology-focused biotech developing targeted therapies for …
|
KZIA | US | Professional, scientific and te… |
|
Keros Therapeutics, Inc.
Develops protein therapeutics for disorders linked to TGF-β…
|
KROS | US | Professional, scientific and te… |
|
KIM FOREST ENTERPRISE CO., LTD.
Offers integrated precision medicine and molecular diagnost…
|
6645 | TW | Professional, scientific and te… |
|
Kura Oncology, Inc.
Clinical-stage biopharma company developing precision medic…
|
KURA | US | Professional, scientific and te… |
|
LAB Research Inc.
Global non-clinical CRO specializing in contract research, …
|
LRI | CA | Professional, scientific and te… |
|
Laekna, Inc.
Clinical-stage biotech developing novel therapies for oncol…
|
2105 | HK | Professional, scientific and te… |
|
Larimar Therapeutics, Inc.
A clinical-stage biotech developing treatments for complex …
|
LRMR | US | Professional, scientific and te… |
|
Lexaria Bioscience Corp.
A biotech company with a patented platform to improve oral …
|
LEXX | US | Professional, scientific and te… |
|
LigaChem Biosciences Inc.
Clinical-stage biopharma developing ADCs, immuno-oncology d…
|
141080 | KR | Professional, scientific and te… |
GENINCODE PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7669/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7669 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7669 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7669 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7669}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENINCODE PLC (id: 7669)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.